Jonathan M. Levitt

University of Wolverhampton — United Kingdom

Immunology and Microbiology · Life Sciences

34h-index3.0kcitations161works12.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(37), scientometrics and bibliometrics research(36), Cancer Immunotherapy and Biomarkers(15), Meta-analysis and systematic reviews(15), Immune Cell Function and Interaction(14)

Publications161 total

Exploring ChatGPT as a tool for adjustment to sight loss
British Journal of Visual Impairment·2025Open Access
Which international co‐authorships produce higher quality journal articles?
Journal of the Association for Information Science and Technology·2024· 24 citedOpen Access
Identifying disability-related barriers to academic employment
Studies in Higher Education·2023· 3 citedOpen Access
Do bibliometrics introduce gender, institutional or interdisciplinary biases into research evaluations?
Research Policy·2023· 22 citedOpen Access
In which fields do higher impact journals publish higher quality articles?
Scientometrics·2023· 22 citedOpen Access
In which fields are citations indicators of research quality?
Journal of the Association for Information Science and Technology·2023· 46 citedOpen Access
Does the perceived quality of interdisciplinary research vary between fields?
Journal of Documentation·2023· 8 citedOpen Access
Supplementary Methods, Figure Legend from FGFR1–WNT–TGF-β Signaling in Prostate Cancer Mouse Models Recapitulates Human Reactive Stroma
2023Open Access
Supplementary Figures 1-8 from Enhanced Activation of Human Dendritic Cells by Inducible CD40 and Toll-like Receptor-4 Ligation
2023Open Access
Data from FGFR1–WNT–TGF-β Signaling in Prostate Cancer Mouse Models Recapitulates Human Reactive Stroma
2023Open Access
Supplementary Methods from Enhanced Activation of Human Dendritic Cells by Inducible CD40 and Toll-like Receptor-4 Ligation
2023Open Access
Data from Enhanced Activation of Human Dendritic Cells by Inducible CD40 and Toll-like Receptor-4 Ligation
2023Open Access
Supplementary Figures 1 - 8 from FGFR1–WNT–TGF-β Signaling in Prostate Cancer Mouse Models Recapitulates Human Reactive Stroma
2023Open Access
Supplementary Figures 1-8 from Enhanced Activation of Human Dendritic Cells by Inducible CD40 and Toll-like Receptor-4 Ligation
2023Open Access
Data from FGFR1–WNT–TGF-β Signaling in Prostate Cancer Mouse Models Recapitulates Human Reactive Stroma
2023Open Access
Supplementary Figures 1 - 8 from FGFR1–WNT–TGF-β Signaling in Prostate Cancer Mouse Models Recapitulates Human Reactive Stroma
2023Open Access
Supplementary Methods from Enhanced Activation of Human Dendritic Cells by Inducible CD40 and Toll-like Receptor-4 Ligation
2023Open Access
Supplementary Methods, Figure Legend from FGFR1–WNT–TGF-β Signaling in Prostate Cancer Mouse Models Recapitulates Human Reactive Stroma
2023Open Access
Data from Enhanced Activation of Human Dendritic Cells by Inducible CD40 and Toll-like Receptor-4 Ligation
2023Open Access
Author response for "Is Research Funding Always Beneficial? A Cross-Disciplinary Analysis of UK Research 2014–20"
2023
page 1 of 9Next →

Frequent Co-authors

Mike Thelwall(17), Kayvan Kousha(7), Emma Stuart(7), Meiko Makita(7), Mahshid Abdoli(7), Paul Wilson(7), Vanaja Konduri(6), William K. Decker(6), Mamatha Seethammagari(6), Kevin M. Slawin(6), David M. Spencer(6), Matthew M. Halpert(5), Irene Georgakoudi(5), Karl Münger(4), Natalia Lapteva(4), Damilola Oyewole-Said(3), Jonathan Vazquez‐Perez(3), Dan Liang(3), Silke Paust(3), Seth P. Lerner(3)